Active cytomegalovirus replication in patients with coronary disease

Scandinavian Cardiovascular Journal

Volumn 41, Issue 4, 2007, Pages 230-234

  Gredmark, Sara ^a   Jonasson, Lena ^b   Van Gosliga, Djoke ^a   Ernerudh, Jan ^b   Söderberg Nauclér, Cecilia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute coronary syndrome; Coronary artery disease; Cytomegalovirus; Monocytes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN T; VIRUS RNA;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; BLOOD SAMPLING; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STABLE ANGINA PECTORIS; VIRUS REACTIVATION; VIRUS REPLICATION;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS REPLICATION;

EID: 34547857427     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430701383755     Document Type: Article

References (24)

1. Hansson, GK, Libby, P., Schonbeck, U. and Yan, ZQ. (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res., 91, pp. 281-291.
2. Mayr, M., Kiechl, S., Willeit, J., Wick, G. and Xu, Q. (2000) Infections, immunity, and atherosclerosis: Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation., 102, pp. 833-839.
3. Zhu, J., Nieto, FJ, Horne, BD, Anderson, JL, Muhlestein, JB and Epstein, SE. (2001) Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation., 103, pp. 45-51.
4. Soderberg-Naucler, C., Fish, KN and Nelson, JA. (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell., 91, pp. 119-126.
5. Melnick, JL, Burek, J., Adam, E. and DeBakey, ME. (1994) Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol., 42, pp. 170-174.
6. Hendrix, MG, Salimans, MM, van Boven, CP and Bruggeman, CA. (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol., 136, pp. 23-28.
7. Streblow, DN, Soderberg-Naucler, C., Vieira, J., Smith, P., Wakabayashi, E. and Ruchti, F. (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell., 99, pp. 511-520.
8. Zhou, YF, Leon, MB, Waclawiw, MA, Popma, JJ, Yu, ZX and Finkel, T. (1996) Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med., 335, pp. 624-630.
9. Ridker, PM, Hennekens, CH, Stampfer, MJ and Wang, F. (1998) Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation., 98, pp. 2796-2799.
10. Zhu, J., Quyyumi, AA, Norman, JE, Csako, G., Waclawiw, MA and Shearer, GM (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol., 85, pp. 140-146.
11. Blankenberg, S., Rupprecht, HJ, Bickel, C., Espinola-Klein, C., Rippin, G. and Hafner, G. (2001) Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation., 103, pp. 2915-2921.
12. Muhlestein, JB, Horne, BD, Carlquist, JF, Madsen, TE, Bair, TL and Pearson, RR (2000) Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation., 102, pp. 1917-1923.
13. Halcox, JP and Deanfield, JE. (2004) Beyond the laboratory: Clinical implications for statin pleiotropy. Circulation., 109, p. II42.
14. Horne, BD, Muhlestein, JB, Carlquist, JF, Bair, TL, Madsen, TE and Hart, NI (2003) Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease. Circulation., 107, pp. 258-263.
15. Soderberg, C., Larsson, S., Bergstedt-Lindqvist, S. and Moller, E. (1993) Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol., 67, pp. 3166-3175.
16. Haider, AW, Wilson, PW, Larson, MG, Evans, JC, Michelson, EL and Wolf, PA (2002) The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: A prospective study. J Am Coll Cardiol., 40, pp. 1408-1413.
17. Taylor-Wiedeman, J., Sissons, JG, Borysiewicz, LK and Sinclair, JH. (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol., 72, pp. 2059-2064.
18. Britt, WA and Alford, CA. (1996) Cytomegalovirus. Fields Virology, 2, pp. 2493-2523. Lippincott-Raven Publishers, Philiadelphia
19. Mori, T., Kameda, H., Ogawa, H., Iizuka, A., Sekiguchi, N. and Takei, H. (2004) Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy. J Rheumatol., 31, pp. 1349-1351.
20. Cortez, KJ, Fischer, SH, Fahle, GA, Calhoun, LB, Childs, RW and Barrett, AJ (2003) Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis., 188, pp. 967-972.
21. Mehta, SK, Stowe, RP, Feiveson, AH, Tyring, SK and Pierson, DL. (2000) Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis., 182, pp. 1761-1764.
22. Soderberg-Naucler, C., Streblow, DN, Fish, KN, Allan-Yorke, J., Smith, PP and Nelson, JA. (2001) Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol., 75, pp. 7543-7554.
23. Jonasson, L., Tompa, A. and Wikby, A. (2003) Expansion of peripheral CD8+ T cells in patients with coronary artery disease: Relation to cytomegalovirus infection. J Intern Med., 254, pp. 472-478.
24. Potena, L., Frascaroli, G., Grigioni, F., Lazzarotto, T., Magnani, G. and Tomasi, L. (2004) Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. Circulation., 109, pp. 532-536.